Snowball logo
logo
ALPM_logo

Astellas Pharma Inc

ALPMY β€’ PINK
$16.27+$0.35Β  (2.2%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20222023202420252026TTM
Revenue
Total revenue
1,296,1631,518,6191,603,6721,912,3232,268,258.32,411,817.8
COGS
281,292326,789292,485349,206577,240.1642,872.6
Gross Profit
1,014,8711,191,8301,311,1871,563,1171,691,018.21,768,945.2
Operating Expenses & Income
Operating Income
155,686285,43025,51841,039445,009.1538,549.9
Total Operating Expenses
794,850906,4001,285,6691,522,0781,246,009.11,230,395.3
R&D Expenses
246,010276,128294,200327,651333,813.5454,100.6
Selling General & Admin Expenses
548,840630,272740,110843,032860,312-
Earnings from Continuing Operations
Interest Expense
(4,949)(8,779)(12,005)(17,677)(14,920.7)(13,851.7)
Interest Income
6,1498,11011,4557,8748,026-
Income Tax Expense
32,80033,6477,924(19,510)90,140113,497.4
Net Income
Net Income
124,08698,71417,04550,747309,116.8384,236.4
Supplemental
EBIT
161,835141,14036,97448,914445,009.1529,155.9
EBITDA
241,519246,878194,814248,046651,338.6531,896.8
In millions of USD, except % and values per 1 share